Four mutations in transmembrane domains of the mitochondrial ADP/ATP carrier increase resistance to bongkrekic acid.

Zeman, Igor; Schwimmer, Christine; Postis, Vincent; Brandolin, Gérard; David, Claudine; Trézéguet, Véronique; Lauquin, Guy J M

Zeman, Igor; Schwimmer, Christine; Postis, Vincent; Brandolin, Gérard; David, Claudine; Trézéguet, Véronique; Lauquin, Guy J M.

Affiliation

Zeman I; Department of Biochemistry, Faculty of Sciences, Comenius University, Mlynská dolina CH-1, 842 15 Bratislava, Slovakia.

J Bioenerg Biomembr ; 35(3): 243-56, 2003 Jun.

Article in En | MEDLINE | ID: mdl-13678275

Subject(s)

Atractyloside/analogs & derivatives; Bongkrekic Acid/pharmacology; Drug Resistance, Bacterial/genetics; Mitochondrial ADP, ATP Translocases/antagonists & inhibitors; Mitochondrial ADP, ATP Translocases/genetics; Point Mutation/physiology; Anti-Bacterial Agents/pharmacology; Atractyloside/pharmacology; Membrane Proteins/antagonists & inhibitors; Membrane Proteins/chemistry; Membrane Proteins/genetics; Mitochondrial ADP, ATP Translocases/chemistry; Mitochondrial Proteins/antagonists & inhibitors; Mitochondrial Proteins/chemistry; Mitochondrial Proteins/genetics; Protein Conformation; Saccharomyces cerevisiae Proteins

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Atractyloside / Bongkrekic Acid / Mitochondrial ADP, ATP Translocases / Point Mutation / Drug Resistance, Bacterial Language: En Journal: J Bioenerg Biomembr Year: 2003 Document type: Article Affiliation country: Slovakia Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links